Search
170 studies match these filters. Showing 126–150 of 170 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT05712200 | Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) A study to evaluate the effect of abelacimab relative to placebo on the rate of ischemic stroke or systemic embolism (SE) in patients with Atrial Fibrillation (AF) who have been deemed by their responsible physicians or by their own decision to be unsuitable for oral anticoagulation therapy. ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 789 sites in total · contact listed | Recruiting | Phase 3 | 2,500target | 789 / 35 | 2022 | Jul 13, 2026 | |
| NCT06582810 | Lidocaine Infusion Treatment for Subarachnoid Hemorrhage Headaches The goal of this observational study is to evaluate intravenous lidocaine efficacy and safety in treating headache following non-traumatic subarachnoid hemorrhage. Through this prospective analysis, the investigators hope to: 1. show that intravenous lidocaine infusion causes a clinically significa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · contact listed | Recruiting | 20target | 1 / 1 | 2025 | Jul 10, 2026 | ||
| NCT05378347 | Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follo… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 68 sites in total · contact listed | Recruiting | Not applicable | 600target | 68 / 12 | 2023 | Jul 6, 2026 | |
| NCT06527222 | A Study of Ranolazine in ALS The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed | Recruiting | Phase 2 | 72target | 6 / 1 | 2025 | Nov 18, 2026 | |
| NCT07654374 | A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) This is randomized, double-blind, placebo-controlled study of the long-term efficacy, safety, and tolerability of multiple doses of aleniglipron in participants living with overweight or obesity and T2DM. Participants will be randomized to aleniglipron or placebo for a total of 76 weeks of treatment. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 74 sites in total · contact listed | Recruiting | Phase 3 | 1,100target | 74 / 1 | 2026 | Oct 20, 2026 | |
| NCT06847321 | Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental decline in the last year and who have P. gingivalis (Pg) infection. P. gingivalis infection has been linked to the development of dementia. LHP588 is designed to target the P.… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 39 sites in total · contact listed | Recruiting | Phase 2 | 300target | 39 / 1 | 2025 | Oct 7, 2026 | |
| NCT05172973 | ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves The objective of this study is to establish the safety and effectiveness of the Edwards SAPIEN X4/X4S Transcatheter Heart Valve (THV) in subjects who are at high or greater risk with a failing aortic bioprosthetic valve. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 37 sites in total | Recruiting | Not applicable | 200target | 37 / 2 | 2023 | Oct 7, 2026 | |
| NCT07069673 | Abbott Cephea Mitral Valve Disease Registry The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of cor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 24 sites in total · contact listed | Recruiting | 1,000target | 24 / 1 | 2025 | Sep 10, 2026 | ||
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy and immunotherapy (chemo-immunotherapy) for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. Inotuzumab ozogamicin is a monoclonal antibody, which is a type of protei… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total · contact listed | Recruiting | Phase 3 | 5,951target | 231 / 5 | 2019 | Aug 25, 2026 | |
| NCT07654361 | Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calor… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 71 sites in total · contact listed | Recruiting | Phase 3 | 3,600target | 71 / 1 | 2026 | Aug 10, 2026 | |
| NCT06533644 | A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected dose for phase 2b study. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total | Recruiting | Phase 2 | 91target | 23 / 1 | 2025 | Jun 23, 2026 | |
| NCT05491525 | Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 38 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 71target | 38 / 16 | 2022 | Jun 15, 2026 | |
| NCT07382167 | A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults This is a 26-week, multi-center, randomized, double-blind, placebo-controlled study with a 4-week treatment-free Safety Follow-up period to assess the safety and efficacy of tenapanor (5 mg, 25mg, and 50 mg) in adult patients with Chronic Idiopathic Constipation (CIC) when administered twice daily f… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 3 | 692target | 109 / 1 | 2026 | Jun 4, 2026 | |
| NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease The goal of this clinical trial is to learn if pridopidine can slow the clinical decline of Huntington's Disease (HD) in adult participants. It will also inform about the safety of pridopidine. The main questions the study aims to answer are: Does pridopidine slow the overall worsening of HD over… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 66 sites in total · contact listed | Recruiting | Phase 3 | 400target | 66 / 12 | 2026 | Nov 19, 2026 | |
| NCT05675410 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 419 sites in total · contact listed | Recruiting | Phase 3 | 1,875target | 419 / 3 | 2023 | Nov 12, 2026 | |
| NCT06693895 | A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age The purpose of this study is to assess how well-tolerated GSK's investigational varicella vaccine (VNS Vaccine) is, in comparison to an already approved varicella vaccine (VV) known as Varivax. The study will be conducted on healthy children aged 12 to 15 months, and who have neither contracted vari… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 46 sites in total | Recruiting | Phase 3 | 750target | 46 / 8 | 2024 | May 29, 2026 | |
| NCT03851445 | Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will deter… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 1,229 sites in total | Recruiting | Phase 2 / Phase 3 | 10,000target | 1,229 / 1 | 2019 | May 18, 2026 | |
| NCT03067181 | Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 629 sites in total · contact listed | Recruiting | Phase 3 | 1,780target | 629 / 9 | 2017 | Aug 25, 2026 | |
| NCT07546929 | HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes Blood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. Insulin binds to cel… ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 25 sites in total · contact listed | Recruiting | Phase 2 | 300target | 25 / 1 | 2023 | Apr 23, 2026 | |
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 832 sites in total · contact listed | Recruiting | Phase 3 | 1,670target | 832 / 4 | 2021 | Apr 23, 2026 | |
| NCT06438315 | SuperSaturated Oxygen Comprehensive Observational Registry The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility, infarct size reduction, and cost-effectiveness of SSO2 Therapy versus PCI alone among patients with anterior AMI in routine clinical practice. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 27 sites in total · contact listed | Recruiting | 1,000target | 27 / 1 | 2024 | Nov 2, 2026 | ||
| NCT07606066 | A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions. ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 76 sites in total | Recruiting | 2,150target | 76 / 7 | 2026 | Aug 25, 2026 | ||
| NCT07282743 | Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus This is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatment arms (GL0034, on… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 21 sites in total | Recruiting | Phase 2 | 285target | 21 / 2 | 2026 | Mar 18, 2026 | |
| NCT06906562 | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 2 | 40target | 109 / 1 | 2025 | Feb 17, 2026 | |
| NCT04729114 | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their canc… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total | Recruiting | Phase 1 | 174target | 25 / 2 | 2021 | Feb 4, 2026 |